Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Centre Hospitalier Universitaire Vaudois (Chuv) has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are handled by 2 distinct examiners and 2 distinct art units. KARI KRISTIN RODRIQUEZ is the busiest examiner for the portfolio with 1 pending action. The presence of 2 pending office actions indicates an active prosecution phase for the company's medical device innovations.
Because each action is in a different art unit and assigned to a different examiner, the company's filings are being reviewed by different experts in specialized fields. This distribution across 2 distinct art units and 2 distinct examiners suggests that the company's current research is not concentrated in a single niche. Managing 2 pending office actions requires the company to navigate two separate sets of examiner preferences and unit-specific guidelines. This variety in the prosecution environment means that the company's legal team must be prepared for different technical interpretations and procedural approaches for each of its active matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RODRIQUEZ, KARI KRISTIN | 1 | 55.1% | +38.4% |
| MARTIN, PAUL C | 1 | 41.8% | +21.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19105594 | Customized Modular Multi-Material Mouthguard and Method of Making the Same | RODRIQUEZ, KARI KRISTIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19105594 | Customized Modular Multi-Material Mouthguard and Method of Making the Same | RODRIQUEZ, KARI KRISTIN | — |
| 18288893 | SINGLE VESSEL EXPANSION OF LYMPHOCYTES | MARTIN, PAUL C | — |
| Art Unit | Apps |
|---|---|
| 3786 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19105594 | Customized Modular Multi-Material Mouthguard and Method of Making the Same | RODRIQUEZ, KARI KRISTIN | 3786 | §102§103§112 | Non-Final OA | — | Pending | Feb 21, 2025 |
| 18288893 | SINGLE VESSEL EXPANSION OF LYMPHOCYTES | MARTIN, PAUL C | 1653 | §102§103§112DP | Non-Final OA | — | Pending | Oct 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial